Overview
Decades of Tourette Syndrome (TS) neuroimaging research has revealed abnormal cortical and subcortical motor system network, hypothesized to result from maladaptive plasticity. Repetitive transcranial magnetic stimulation ([r]TMS) is a promising technology that utilizes the concept of neuroplasticity to modulate brain circuits. TMS modulation has the distinct advantage in terms of its non-invasive nature. Furthermore, unique stimulation paradigms such as intermittent theta-burst repetitive TMS (iTBS) allows for short stimulation time (<3 min).
Using a sham-controlled protocol, the investigators propose modulating pre-SMA output using iTBS, based on our prior data of abnormal pre-SMA-mediated motor system regulation. hypothesize pre-SMA modulation results in increased pre-SMA-mediated motor inhibition. Enhancing these inhibitory measures with pre-SMA-iTBS provides the basis for improving inhibitory function in TS patients, leading to our long-term goal of neuro-stimulation to achieve clinical tic reduction.
Eligibility
Inclusion Criteria:
Participants of any sex, race, or ethnicity meeting all criteria listed below will be
included in the study:
1. Aged 10-21 years
2. Fluent in English
3. DSM-5 diagnosis of TS, confirmed by the clinical team
4. Able to participate in the informed consent process, provide voluntary informed
consent/assent and provide a spontaneous narrative description of the key elements of
the study.
5. Clinical stability: determined by a physician, no switch of psychotropic medications
or increase in dosage in the last 14 days from TMS treatment start; no change in other
therapeutic interventions in last 14 days from TMS treatment start.
Exclusion Criteria:
1. Any neurodevelopmental, psychiatric condition other than TS, ADHD, or OCD, or mild
anxiety based on review of K-SADS. Note - if an exclusionary psychiatric diagnosis is
suspected based on K-SADS, the research physician will follow up with the parent and
referral will be made to psychology or psychiatry as appropriate.
2. Presence of metallic foreign bodies or implanted medical devices.
3. Not meeting inclusion criteria as described above
4. Non-fluency in English, as English is the language in the validated clinical
questionnaires, and the participant must be able to understand real-time instructions
from the study staff